Greenland Mines Ltd (NASDAQ: GRML) announced that IP Australia has granted Australian Patent No. 2023252508 covering gene therapy technology exclusively licensed by the company’s Biotech Division for the treatment of neuromuscular diseases through expression of the human Klotho protein. The patent strengthens the intellectual property supporting Greenland Mines’ Klotho-based therapeutic platform and includes claims covering gene therapy constructs, neuronal and induced pluripotent stem cells, and viral and non-viral delivery systems. The company said the patent further supports development of its KLTO-202 program targeting amyotrophic lateral sclerosis (“ALS”) and other neuromuscular disorders.
The granted patent is a significant milestone for Greenland Mines as it reinforces the company’s position in the gene therapy space. The patent’s broad claims cover various aspects of the Klotho gene therapy platform, including constructs and delivery methods, which could provide a competitive advantage in developing treatments for ALS and other neuromuscular conditions. The company’s Biotech Division is focused on advancing the KLTO-202 program, which aims to address the substantial unmet medical need in ALS, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.
Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and Biotech, including Klotho’s KLTO-202 primary indication for ALS. The company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
For more information, visit the full press release at https://nnw.fm/PVbbH and the company’s newsroom at https://nnw.fm/GRML.
